Sigma Planning Corp Vertex Pharmaceuticals Inc Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sigma Planning Corp holds 2,746 shares of VRTX stock, worth $1.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,746

Previous 3,007 8.68%

Holding current value

$1.28 Million

Previous $1.41 Million 9.37%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$460.0 - $505.78 $120,060 - $132,008	-261 Reduced 8.68%	2,746 $1.28 Million
Q2 2024 Aug 05, 2024	BUY	$392.81 - $485.53 $5,499 - $6,797	14 Added 0.47%	3,007 $1.41 Million
Q1 2024 May 01, 2024	BUY	$407.69 - $446.08 $494,120 - $540,648	1,212 Added 68.05%	2,993 $1.25 Million
Q4 2023 Feb 01, 2024	SELL	$343.0 - $410.68 $363,923 - $435,731	-1,061 Reduced 37.33%	1,781 $724,000
Q3 2023 Nov 06, 2023	BUY	$338.18 - $362.46 $27,054 - $28,996	80 Added 2.9%	2,842 $988,000
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $3,144 - $3,519	10 Added 0.36%	2,762 $971,000
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $116,690 - $133,117	-412 Reduced 13.02%	2,752 $867,000
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $12,573 - $14,145	44 Added 1.41%	3,164 $0
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $296,284 - $330,583	1,082 Added 53.09%	3,120 $903,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $125,703 - $156,514	535 Added 35.6%	2,038 $574,000
Q1 2022 Apr 20, 2022	SELL	$221.42 - $260.97 $24,799 - $29,228	-112 Reduced 6.93%	1,503 $392,000
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $211,172 - $266,575	-1,193 Reduced 42.49%	1,615 $355,000
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $217,849 - $243,790	1,201 Added 74.74%	2,808 $509,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $73,121 - $86,229	390 Added 32.05%	1,607 $324,000
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $4,554 - $5,308	22 Added 1.84%	1,217 $262,000
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $247,376 - $329,927	1,195 New	1,195 $282,000
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $2.3 Million - $2.73 Million	-9,006 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$225.48 - $295.8 $2.03 Million - $2.66 Million	9,006 New	9,006 $2.62 Million
Q1 2020 May 01, 2020	SELL	$199.77 - $247.81 $220,546 - $273,582	-1,104 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$166.71 - $223.91 $184,047 - $247,196	1,104 New	1,104 $242,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Vertex Pharmaceuticals Inc Transaction History